Digital innovations such as ePRO and eCOA are streamlining clinical trials, boosting participant engagement, and improving ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...

Pediatric dermatologists reported they are not fairly compensated for educating primary care residents and struggle to ...

Subtle symptoms of MS are often overlooked in patients with minimal disability, but clinical tools can help detect them early ...

Researchers at the Indiana University Indianapolis Fairbanks School of Public Health have released updated findings that ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

A University of Maine study has compared how well artificial intelligence models and human clinicians handled complex or ...

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced the completion of enrollment in the Phase ...

The trial evaluated the combination of GSK’s Jemperli and Zejula as a first-line therapy for stage III and IV epithelial OC.

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.